Business EconomyPosted at: Nov 8 2025 12:26AM


Partners Group completes acquisition of Infinity Fincorp

Chennai, Nov 7 (UNI) Non-banking finance company (NBFC) Infinity Fincorp Solutions, focused on India’s micro, small, and medium enterprises (MSME) sector, on Friday announced the completion of its acquisition by Partners Group, one of the largest firms in the global private markets industry, acting on behalf of its clients as a majority investor.
The transaction, which received RBI approval in October 2025, is valued at approximately Rs 1,950 crore (USD 230 million) and includes a primary capital infusion of about Rs 600 crore (USD 70 million) to fund future expansion, along with a secondary share purchase from existing shareholders, including Indium IV (Mauritius) Holdings.
As part of the transaction, Jungle Ventures, one of Infinity’s early institutional investors, deepened its commitment to the company by participating in the current primary round with an investment of Rs 128 crore (USD 15 million).
With this, Partners Group becomes the majority shareholder, while Jungle Ventures continues on the cap table as a long-term investor. Archerman Capital and Beams Fintech Fund also remain on the cap table as valued partners in the company’s growth journey.
Founded by Shrikant Ravalkar, Infinity has built a strong presence in property-backed, small-ticket secured lending to MSMEs across India’s underserved Tier 2 and Tier 3 cities.
The company currently operates more than 120 branches across eight states, serving around 50,000 customers, with assets under management exceeding Rs 1,450 crore (USD 160 million).
Commenting on the transaction, Shrikant Ravalkar, Founder, MD & CEO of Infinity Fincorp Solutions Pvt Ltd, said, “We are deeply humbled by the confidence and support shown by Partners Group, Jungle Ventures, Archerman Capital and Beams Fintech Fund in Infinity Fincorp Solutions Pvt Ltd. This partnership will go a long way in empowering entrepreneurs and business owners across Tier 3 and beyond, through flexible, need-based lending solutions designed to create lasting impact.”
UNI VJ SQ RKM
Please log in to get detailed story.
Tags: #Partners Group completes acquisition of Infinity Fincorp
More News

Brookfield, FedEx to set up GCCs in Mumbai

14 Dec 2025 | 1:39 AM

Mumbai, Dec 13 (UNI) Global alternative asset management and investment firm, Brookfield as well as FedEx Corporation plan to set up Asia’s largest global capability centre (GCC) in Mumbai, Maharashtra Chief Minister Devendra Fadnavis has announced.

see more..

Kerala boasts cost-effective ecosystem of space vendors: Experts at Huddle Global 2025

14 Dec 2025 | 1:02 AM

Thiruvananthapuram, Dec 13 (UNI) Kerala has a very cost-effective and mature ecosystem of space vendors that would help the country become a global vendor in the sector, said experts today at Huddle Global 2025.

see more..

AP: Ponduru Khadi from Srikakulam receives prestigious GI Tag

13 Dec 2025 | 8:22 PM

Srikakulam, (Andhra Pradesh), Dec 13 (UNI) After years of sustained efforts involving extensive documentation, meetings, and follow-ups, Ponduru Khadi, a traditional handwoven fabric from Srikakulam district, has been awarded the prestigious Geographical Indication (GI) tag, union Civil Aviation Minister Kinjarapu Ram Mohan Naidu on Saturday.
Ram Mohan Naidu, also a native of Srikakulam, expressed immense pride over the achievement.

see more..

SBI report flags marginal rise in inflation but sees comfort on prices and rates

13 Dec 2025 | 2:37 PM

New Delhi, Dec 13 (UNI) India’s retail inflation has shown a marginal reversal in November 2025 but remains at a comfortable level, with overall price pressures still muted, according to SBI Research’s latest Ecowrap report released on Saturday here.

see more..

Ozempic ® - world’s most prescribed GLP-1is now available in India

13 Dec 2025 | 4:02 AM

Hyderabad, Dec 12 (UNI) Novo Nordisk, a global healthcare company, on Friday announced the launch of its once-weekly diabetes drug Ozempic® (injectable semaglutide) in India, marking a significant addition to the country’s treatment options for type 2 diabetes.
The therapy, a GLP-1 receptor agonist, is approved as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes mellitus (T2DM).

see more..